These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 31118063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P.
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [Abstract] [Full Text] [Related]

  • 3. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, Caiello I, Davì S, Schulert G, Ravelli A, Grom AA, de Min C, De Benedetti F.
    Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321
    [Abstract] [Full Text] [Related]

  • 4. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Yasin S, Fall N, Brown RA, Henderlight M, Canna SW, Girard-Guyonvarc'h C, Gabay C, Grom AA, Schulert GS.
    Rheumatology (Oxford); 2020 Feb 01; 59(2):361-366. PubMed ID: 31326996
    [Abstract] [Full Text] [Related]

  • 5. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
    Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G.
    J Pediatr; 2013 Jun 01; 162(6):1245-51. PubMed ID: 23333131
    [Abstract] [Full Text] [Related]

  • 6. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA.
    Ann Rheum Dis; 2020 Feb 01; 79(2):225-231. PubMed ID: 31707357
    [Abstract] [Full Text] [Related]

  • 7. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A.
    Clin Exp Immunol; 2018 Mar 01; 191(3):349-355. PubMed ID: 28815559
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
    Krei JM, Møller HJ, Larsen JB.
    Clin Exp Immunol; 2021 Feb 01; 203(2):174-182. PubMed ID: 33128796
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
    Huang S, Liu Y, Yan W, Zhang T, Wang P, Zhu M, Zhang X, Zhou P, Fan Z, Yu H.
    Pediatr Rheumatol Online J; 2024 May 23; 22(1):58. PubMed ID: 38783316
    [Abstract] [Full Text] [Related]

  • 12. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M, Aktay-Ayaz N, Gemici H, Annayev A, Çıtak A, Akçay A, Öztürk G.
    Turk J Pediatr; 2018 May 23; 60(5):598-603. PubMed ID: 30968645
    [Abstract] [Full Text] [Related]

  • 13. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
    Vastert SJ, Prakken BJ.
    Nat Rev Rheumatol; 2014 Nov 23; 10(11):640-2. PubMed ID: 25201384
    [Abstract] [Full Text] [Related]

  • 14. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM, Dubko MF, Masalova VV, Snegireva LS, Kornishina TL, Chikova IA, Likhacheva TS, Isupova EA, Glebova NI, Kuchinskaya EM, Balbotkina EV, Buchinskaya NV, Kalashnikova OV, Chasnyk VG.
    Semin Arthritis Rheum; 2015 Feb 23; 44(4):417-22. PubMed ID: 25300700
    [Abstract] [Full Text] [Related]

  • 15. The History of Macrophage Activation Syndrome in Autoimmune Diseases.
    Silverman ED.
    Adv Exp Med Biol; 2024 Feb 23; 1448():21-31. PubMed ID: 39117805
    [Abstract] [Full Text] [Related]

  • 16. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
    Inoue N, Schulert GS.
    Arthritis Res Ther; 2023 Mar 25; 25(1):48. PubMed ID: 36964620
    [Abstract] [Full Text] [Related]

  • 17. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, Hirsch R.
    J Rheumatol; 2013 Jul 25; 40(7):1191-9. PubMed ID: 23678162
    [Abstract] [Full Text] [Related]

  • 18. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
    Batu ED, Sener S, Balık Z, Bayındır Y, Cam V, Kasap Cuceoglu M, Uysal O, Aliyev E, Basaran Ö, Bilginer Y, Özen S.
    Clin Rheumatol; 2024 Jan 25; 43(1):415-421. PubMed ID: 38012469
    [Abstract] [Full Text] [Related]

  • 19. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
    Schulert GS, Yasin S, Carey B, Chalk C, Do T, Schapiro AH, Husami A, Watts A, Brunner HI, Huggins J, Mellins ED, Morgan EM, Ting T, Trapnell BC, Wikenheiser-Brokamp KA, Towe C, Grom AA.
    Arthritis Rheumatol; 2019 Nov 25; 71(11):1943-1954. PubMed ID: 31379071
    [Abstract] [Full Text] [Related]

  • 20. Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH.
    De Matteis A, Colucci M, Rossi MN, Caiello I, Merli P, Tumino N, Bertaina V, Pardeo M, Bracaglia C, Locatelli F, De Benedetti F, Prencipe G.
    Blood; 2022 Jul 21; 140(3):262-273. PubMed ID: 35500103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.